Rapid advances in next-generation sequencing (NGS) technology over the past decade have led to a paradigm shift cancer treatment from one-size-fits-all medicine genomics-based precision that has become more accessible general clinical practice. It, however, helped only less than 10% of patients who taken genomic profiling tests. Proteomics-based rather approaches can capture biological processe...